全球中風管理市場規模、佔有率和成長分析：按診斷、按最終用戶 - 產業預測（2023-2030）

Global Stroke Management Market Size, Share, Growth Analysis, By Diagnosis(Imaging, blood tests), By End user (Hospitals, clinics) - Industry Forecast 2023-2030

出版日期: 2023年09月21日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球卒中管理市場規模預計到 2023 年將達到 151.1 億美元，到 2030 年將達到 331.9 億美元，在預測期內（2023-2030 年）年複合成長率為 11.9%。

高齡化和中風風險意識不斷增強等要素正在推動市場成長。遠端醫療和影像領域的技術創新有助於改善診斷和治療方法。總體而言，市場專注於整體中風管理，以實現最佳患者福祉，包括急性介入、復健支持和長期管理。

促進因素

市場成長促進因素包括增加對醫療基礎設施的投資、對創新技術和遠端醫療選擇的接受程度不斷提高。這些趨勢支持中風的早期發現和有效干涉，從而改善患者的治療結果和健康。

抑制因素

無障礙挑戰

某些地區的認知有限、治療成本上升以及中風管理技術與當前醫療保健系統難以協調，市場成長受到阻礙，所有這些都限制了市場擴張的全部潛力。

市場趨勢

近年來，市場取得了顯著進步。遠端醫療和數位健康解決方案的進步促進了遠端監控和快速介入。 MRI 和 CT 掃描等最先進的影像方法正在提高診斷準確性。包括血管內血栓切除術在內的微創外科手術徹底改變了急性中風的治療方法。此外，製藥創新帶來了更有效的溶栓藥物和神經保護療法。此外，聯合研究和公眾意識活動強調早期發現和降低風險的重要性。這些累積的進步旨在加強中風預防、及時治療和長期康復，最終將改善患者的治療結果並減輕全球中風負擔。

本報告研究分析全球中風管理市場，提供市場動態與預測、細分分析、公司簡介等。

Medtronic (United States)
Stryker Corporation (United States)
Bayer AG (Germany)
Boston Scientific Corporation (United States)
Johnson & Johnson (United States)
Abbott Laboratories (United States)
Penumbra, Inc. (United States)
MicroPort Scientific Corporation (China)
Terumo Corporation (Japan)
Koninklijke Philips NV (Netherlands)
GE Healthcare (United Kingdom)
Siemens Healthineers AG (Germany)
Nihon Kohden Corporation (Japan)
Acandis GmbH (Germany)
Penumbra, Inc. (United States)
Balt Extrusion (France)
Olympus Corporation (Japan)
Integra LifeSciences Holdings Corporation (United States)
Merit Medical Systems, Inc. (United States)
Sirtex Medical Limited (Australia)

簡介目錄

Product Code: SQMIG35A2508

Market Insights

Global Stroke Management Market size was valued at USD 37 billion in 2022 and is poised to grow from USD 15.11 billion in 2023 to USD 33.19 billion by 2030, at a CAGR of 11.9% during the forecast period (2023-2030).

The Global Stroke Management Market encompasses a range of medical solutions and interventions aimed at preventing, diagnosing, and treating strokes. This market involves pharmaceuticals, medical devices, and rehabilitation services, all designed to enhance patient outcomes and quality of life. Factors such as aging populations and increased awareness of stroke risks drive market growth. Innovations in telemedicine and neuroimaging contribute to improved diagnostic and treatment approaches. Overall, the market focuses on holistic stroke care, including acute intervention, recovery support, and long-term management for optimal patient well-being.

Top-down and bottom-up approaches were used to estimate and validate the size of stroke management and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segmental Analysis

The global stroke management market can be segmented based on diagnosis, region, and end-users. Diagnosis includes imaging, blood tests, and physical examination. End-users encompass of hospitals, clinics, and ambulatory surgical centers. Based on region, the market is segmented into North America, Latin America, Asia Pacific, Europe, and MEA.

Drivers

Factors driving the growth of the global stroke management market include the rising investment in healthcare infrastructure and the growing acceptance of innovative technologies and telemedicine options. These trends are boosting early detection and effective intervention for strokes, leading to enhanced patient results and well-being.

Restraints

Accessibility Challenges:

The growth of the worldwide stroke management market is impeded by restricted awareness in specific areas, elevated treatment expenses, and difficulties in harmonizing stroke management technologies with prevailing healthcare systems, all of which curtail its complete potential for expansion.

Market Trends

In recent times, significant progress has been observed within the global stroke management market. Advances in telemedicine and digital healthcare solutions have facilitated remote monitoring and prompt intervention. Cutting-edge neuroimaging methods like MRI and CT scans have elevated the accuracy of diagnoses. Minimally invasive surgical procedures, including endovascular thrombectomy, have brought about a revolution in the treatment of acute strokes. Furthermore, innovations in pharmaceuticals have yielded more efficient clot-dissolving medications and neuroprotective therapies. Collaborative research endeavors and public awareness initiatives have underscored the significance of early detection and risk mitigation. These collective advancements aim to enrich stroke prevention, immediate care, and prolonged rehabilitation, thereby ultimately enhancing patient outcomes and diminishing the global stroke burden.